Patentability of Solutions in the Field of Bioprint Technologies: A Comparative Law Aspect

The paper is devoted to the issues of advisability introducing amendments civil legislation in connection with development additive technologies or possibility effective application existing rules law regulation «innovative» relations. Digitization objects material world associated creation their digital prototypes constitutes a revolutionary element 3D printing technology. A three-dimensional model (CAD file) can be easily modified, distributed and embodied form physical object by it on printer. This gives rise new risks infringement exclusive rights patent law. In foreign doctrine, discussion has started regarding qualifying circulation models patented products (inventions) as direct indirect rights. concluded that Russian was not ready for challenge generated technology, since aware concept right. enforcement practice, interpreted restrictive manner. question admissibility patenting technical solutions field bioprinting been studied. It there are no fundamental obstacles technologies. provides «natural products», well methods means treatment, which distinguishes approach from American European one. If risk genetic instability pluripotent cells leveled, technology creating bioprinted human organs will comply requirements particular, meet compliance public interest, principles humanity morality.